Efavirenz API Market

Efavirenz(CAS?154598-52-4) is an antiretroviral medication used to treat and prevent HIV/AIDS.
Efavirenz API Market aims to provide a comprehensive presentation of the global market for Efavirenz API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Efavirenz API. Efavirenz API Market contains market size and forecasts of Efavirenz API in global, including the following market information:
Global Efavirenz API Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Efavirenz API Market Sales, 2018-2023, 2024-2030, (Kg)
Global top five Efavirenz API companies in 2022 (%)
The global Efavirenz API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Above 98 % Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Efavirenz API include Acebright India Pharma Private Limited, Arene Lifesciences Limited, Dasami Lab, Gonane Pharma, Hetero Drugs, Laurus Labs, Mylan, NEWEDGE Overseas and SMS Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Efavirenz API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Efavirenz API Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (Kg)
Global Efavirenz API Market Segment Percentages, by Type, 2022 (%)
Above 98 %
Above 99 %
Global Efavirenz API Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (Kg)
Global Efavirenz API Market Segment Percentages, by Application, 2022 (%)
Oral Solution
Capsules
Tablets
Others
Global Efavirenz API Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (Kg)
Global Efavirenz API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Efavirenz API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Efavirenz API revenues share in global market, 2022 (%)
Key companies Efavirenz API sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Efavirenz API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Acebright India Pharma Private Limited
Arene Lifesciences Limited
Dasami Lab
Gonane Pharma
Hetero Drugs
Laurus Labs
Mylan
NEWEDGE Overseas
SMS Pharmaceuticals
Mangalam Drugs & Organics Ltd
Shanghai Desano Bio-Pharmaceutical
Guangzhou Topwork Chemical
Jiangsu Zhongbang Pharmaceutical
Nortec Quimica
Globe Quimica Ltda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Efavirenz API, market overview.
Chapter 2: Global Efavirenz API market size in revenue and volume.
Chapter 3: Detailed analysis of Efavirenz API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Efavirenz API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Efavirenz API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.